SEC Form 4 research
| Issuer | Altimmune, Inc. |
|---|---|
| Tickers | ALT, PIP, HAQ |
| Reporting owners | 94 |
| Officers and directors | 29 |
| Last public filing | 2026-11-18 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-18 | 2026-11-18 | MENZIUSO RICHARD THOMAS | P | 10,000 | $1.42 | Not reported |
| 2026-11-13 | 2026-11-13 | WEAVER GREGORY L | P | 10,000 | $1.62 | Not reported |
| 2026-11-13 | 2026-11-13 | Pisano Wayne | P | 10,000 | $1.64 | Not reported |
| 2026-11-13 | 2026-11-13 | Durso Jerome Benedict | P | 30,700 | $1.62 | Not reported |
| 2026-11-04 | 2026-11-02 | Greenleaf Peter | A | 160,000 | $0 | Not reported |
| 2026-11-04 | 2026-11-02 | Howarth Alex G. | A | 160,000 | $0 | Not reported |
| 2026-10-02 | 2026-10-01 | MENZIUSO RICHARD THOMAS | A | 36,234 | $0 | Not reported |
| 2026-10-02 | 2026-10-01 | MENZIUSO RICHARD THOMAS | A | 84,546 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.